NiraWave C is a near-infrared (NIR) fluorescence contrast agent with high protein binding affinity specifically formulated for preclinical optical imaging.
It shows absorption and emission (fluorescence) in the NIR spectral range allowing an increased tissue penetration.
Upon intravenous injection, NiraWave C rapidly binds to plasma proteins and is excreted unchanged by the liver. The plasma clearance is biphasic with an initial half-life of 3–4 minutes and a secondary half-life of more than 1 hour.
Applications
NiraWave C is indicated for use in optical imaging of small animals, for example mice, to facilitate the visualization of the vasculature.